CVS Health Corporation $CVS Shares Sold by Cacti Asset Management LLC

Cacti Asset Management LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 1.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 398,293 shares of the pharmacy operator’s stock after selling 7,067 shares during the period. CVS Health makes up approximately 2.0% of Cacti Asset Management LLC’s portfolio, making the stock its 17th biggest holding. Cacti Asset Management LLC’s holdings in CVS Health were worth $30,179,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after buying an additional 2,063,737 shares in the last quarter. Dodge & Cox grew its position in shares of CVS Health by 4.8% in the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock valued at $4,976,856,000 after buying an additional 3,353,223 shares during the last quarter. State Street Corp boosted its holdings in shares of CVS Health by 1.4% in the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock valued at $4,055,237,000 after acquiring an additional 800,414 shares during the period. Geode Capital Management LLC raised its stake in CVS Health by 2.4% during the 2nd quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after acquiring an additional 675,824 shares during the last quarter. Finally, Invesco Ltd. increased its stake in shares of CVS Health by 15.3% during the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after acquiring an additional 3,118,626 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Down 1.7%

CVS Health stock opened at $79.45 on Monday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15. The firm has a market cap of $100.85 billion, a price-to-earnings ratio of 209.08, a price-to-earnings-growth ratio of 0.78 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm’s 50 day moving average price is $78.97 and its two-hundred day moving average price is $71.98.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday. TD Cowen boosted their price objective on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Piper Sandler reiterated an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a research note on Wednesday. The Goldman Sachs Group lifted their target price on CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 8th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $93.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.